MARSTRAND EVEN has a total of 15 patent applications. Its first patent ever was published in 1968. It filed its patents most often in Denmark, Germany and France. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and mechanical elements are TRIUS THERAPEUTICS, TRIUS THERAPEUTICS INC and BIOKINESIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Denmark | 5 | |
#2 | Germany | 2 | |
#3 | France | 2 | |
#4 | Australia | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | United Kingdom | 1 | |
#7 | Japan | 1 | |
#8 | United States | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Mechanical elements | |
#4 | Civil engineering | |
#5 | Control |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Special acyclic compounds | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Locks | |
#6 | Nails | |
#7 | Control or regulating systems |
# | Name | Total Patents |
---|---|---|
#1 | Marstrand Even | 10 |
#2 | Iibun Marusutorando | 1 |
#3 | Even Marstrand | 1 |
Publication | Filing date | Title |
---|---|---|
DK200500470A | Composition for the treatment of chondromalacia and use of a titanium complex and a selenium salt for the preparation of preparations | |
DK173459B1 | Preparation for the treatment of cancer and ulcerative colitis and the use of a titanium complex and a zinc salt for the preparation of | |
DK60489D0 | Table for prevention of power and blood problems | |
DK283085D0 | Method for normalizing the blood image of human and animals and their method of producing it | |
DK23478A | Analogy procedure for preparing a complex compound of ascorbic acid, trivalent titan and divalent copper | |
US4211712A | Complex compound for the treatment of diseases disclosing abnormal blood pictures | |
GB1549524A | Composition for the treatment of cancer |